Abstract:Transforming growth factor-β (TGF-β) ligand is a multifunctional growth factor that regulates various cell behavior, such as cell proliferation, differentiation, migration, and apoptosis. Because TGF-β is a potent growth inhibitor, abnormalities in TGF-β signaling result in carcinogenesis. In addition to tumor suppressor function, TGF-β acts as an oncogenic factor. In particular, TGF-β signaling plays an important role during metastasis of breast cancer. Recently, epithelial-mesenchymal transition (EMT) has be… Show more
“…The TGF-β growth factor cytokine family is composed of a large number of secreted polypeptides that activate cellular responses involved in development, homeostasis and the immune system (92). In addition, TGF-β1 signalling has been widely reported to have a dual role in the progression of cancer.…”
“…In addition, TGF-β1 signalling has been widely reported to have a dual role in the progression of cancer. While it acts as a tumour suppressor and inhibits cell proliferation during the early stages of carcinogenesis, it promotes migration and metastasis in the late stages of the disease (92). Similar to TBX3, TGF-β1 signalling is critical for the development of the mammary glands but also contributes to breast cancer progression through the inhibition of cell proliferation and promotion of migration (93).…”
“…The TGF-β growth factor cytokine family is composed of a large number of secreted polypeptides that activate cellular responses involved in development, homeostasis and the immune system (92). In addition, TGF-β1 signalling has been widely reported to have a dual role in the progression of cancer.…”
“…In addition, TGF-β1 signalling has been widely reported to have a dual role in the progression of cancer. While it acts as a tumour suppressor and inhibits cell proliferation during the early stages of carcinogenesis, it promotes migration and metastasis in the late stages of the disease (92). Similar to TBX3, TGF-β1 signalling is critical for the development of the mammary glands but also contributes to breast cancer progression through the inhibition of cell proliferation and promotion of migration (93).…”
“…In the advanced stage of carcinogenesis, TGF-acts as an oncogenic factor and induces invasion-associated epithelial-mesenchymal transition. TGF-is thought to enhance tumor growth and invasion through regulation of immune functions and angiogenesis, as well as the production of stromal components [42]. TGF-is secreted as a latent complex containing one of the LTBPs.…”
“…While TGFβ1 inhibits cell growth at an early stage of carcinogenesis, it supports metastasis formation in late‐stage cancer (Imamura et al ., 2012). We have previously shown that TGFβ signaling and TGFβ receptor type‐2 (TGFBR2) seem to have a tumor promoting role in human estrogen receptor (ER)‐negative breast cancer (Keklikoglou et al ., 2012).…”
Breast cancer is the most common cancer in women worldwide. The tumor microenvironment contributes to tumor progression by inducing cell dissemination from the primary tumor and metastasis. TGFβ signaling is involved in breast cancer progression and is specifically elevated during metastatic transformation in aggressive breast cancer. In this study, we performed genomewide correlation analysis of TGFBR2 expression in a panel of 51 breast cancer cell lines and identified that MET is coregulated with TGFBR2. This correlation was confirmed at the protein level in breast cancer cell lines and human tumor tissues. Flow cytometric analysis of luminal and basal‐like breast cancer cell lines and examination of 801 tumor specimens from a prospective cohort of breast cancer patients using reverse phase protein arrays revealed that expression of TGFBR2 and MET is increased in basal‐like breast cancer cell lines, as well as in triple‐negative breast cancer tumor tissues, compared to other subtypes. Using real‐time cell analysis technology, we demonstrated that TGFβ1 triggered hepatocyte growth factor (HGF)‐induced and MET‐dependent migration in vitro. Bioinformatic analysis predicted that TGFβ1 induces expression of C‐ets‐1 as a candidate transcription factor regulating MET expression. Indeed, TGFβ1‐induced expression of ETS1 and breast cancer cell migration was blocked by knockdown of ETS1. Further, we identified that MET is a direct target of miR‐128‐3p and that this miRNA is negatively regulated by TGFβ1. Overexpression of miR‐128‐3p reduced MET expression and abrogated HGF‐induced cell migration of invasive breast cancer cells. In conclusion, we have identified that TGFβ1 regulates HGF‐induced and MET‐mediated cell migration, through positive regulation of C‐ets‐1 and negative regulation of miR‐128‐3p expression in basal‐like breast cancer cell lines and in triple‐negative breast cancer tissue.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.